生物制品行业深度报告:多发性硬化 百亿美金市场 BTKI发展前景广阔

开源证券
Jul 30, 2025

MS 全球存量患者基数较大,减少复发与延缓神经退行是治疗的核心目标多发性硬化(Multiple Sclerosis, MS)是一种由免疫系统介导的中枢神经系统炎性脱髓鞘疾病,“空间多发性”和“时间多发性”是其核心特点。MS 地理分布呈现鲜明的“纬度梯度”现象,高纬度地区发病率较高;根据Frost & Sullivan数据,全球与中国多发性硬化存量患者数量预计将在2030 年达到371/6 万人。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10